Duong, Hong-Quan <br/><br/>
Combination of dasatinib and gemcitabine reduces the ALDH1A1 expression and the proliferation of gemcitabine-resistant pancreatic cancer MIA PaCa-2 cells.  [electronic resource] 

 -  International journal of oncology  Jun 2014 
 - 2132-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1791-2423 
<br/><br/><label>Standard No.: </label>10.3892/ijo.2014.2357  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aldehyde Dehydrogenase--genetics<br/>Aldehyde Dehydrogenase 1 Family<br/>Antineoplastic Agents--pharmacology<br/>Antineoplastic Combined Chemotherapy Protocols<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Dasatinib<br/>Deoxycytidine--analogs & derivatives<br/>Drug Resistance, Neoplasm--drug effects<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Pancreatic Neoplasms--drug therapy<br/>Pyrimidines--pharmacology<br/>Retinal Dehydrogenase<br/>Thiazoles--pharmacology<br/>Gemcitabine